Viking Therapeutics stock (VKTX) slips in premarket after 11% rally as Novo obesity-drug stumble hits tape
Viking Therapeutics slipped 0.5% to $34.30 ahead of Tuesday’s open, following an 11.1% surge the day before that took the stock to a $34.46 close. Monday’s range ran from $32.50 up to $35.73, with roughly 5.68 million shares traded.
